Cite
HARVARD Citation
Clément‐Zhao, A. et al. (2018). Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer. BJU international. pp. 203-208. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Clément‐Zhao, A. et al. (2018). Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer. BJU international. pp. 203-208. [Online].